Rumors of Pfizer bid boost Bayer...again

Will rumors of a Pfizer bid for Bayer ever die? The talk boosted Bayer's stock in Frankfurt earlier today, despite the bankers who've persistently pooh-poohed the idea. Where there's smoke there's fire, perhaps--or maybe traders just like to talk. Report

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.